SCHEMBL23901250

SCHEMBL23901250

CN1CCc2cc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(N)cc2C1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALK Q9UM73 17/20 0.71
INSR P06213 16/20 0.71
IGF1R P08069 10/20 0.71
NTRK1 P04629 6/20 0.62
AURKA O14965 4/20 0.62
AURKB Q96GD4 4/20 0.62
PLK4 O00444 2/20 0.60
DAPK3 O43293 2/20 0.60
PRKCG P05129 2/20 0.60
ROS1 P08922 2/20 0.60
FER P16591 2/20 0.60
LTK P29376 2/20 0.60
FRK P42685 2/20 0.60
MST1R Q04912 2/20 0.60
PTK2 Q05397 2/20 0.60
TNK2 Q07912 2/20 0.60
NTRK3 Q16288 2/20 0.60
MAP4K5 Q9Y4K4 2/20 0.60
WEE1 P30291 1/20 0.60
MAPK8 P45983 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31391690 1.00 ALK (0.71) ALKINSRIGF1RNTRK1AURKA
SCHEMBL28999430 0.89 ALK (0.59) ALKINSRIGF1RNTRK1AURKA
SCHEMBL31391681 0.85 INSR (0.75) ALKINSRIGF1RNTRK1AURKA
SCHEMBL23901251 0.85 INSR (0.75) ALKINSRIGF1RNTRK1AURKA
SCHEMBL3513178 0.83 ALK (1.00) ALKINSRIGF1RNTRK1AURKA
Hydrochloric Acid SCHEMBL3511834 0.82 ALK (0.98) ALKINSRIGF1RNTRK1AURKA
SCHEMBL3512913 0.82 ALK (0.77) ALKINSRIGF1RNTRK1AURKA
SCHEMBL29763783 0.80 ALK (0.72) ALKINSRIGF1RNTRK1AURKA
SCHEMBL3515047 0.80 ALK (0.72) ALKINSRIGF1RNTRK1AURKA
SCHEMBL3512682 0.78 ALK (0.70) ALKINSRIGF1RNTRK1AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021197467-A1 MULTI-TARGET ANTI-TUMOR COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 上海华汇拓医药科技有限公司 2021-10-07 WO disclosed